Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

US Risers & Fallers: Morgan Stanley, UnitedHealth, J&J, Amarantus, Avant, Payment Data

Below are some of the main news-driven share price changes as at 11:33 a.m. in New York.

RISERS

Morgan Stanley (NYSE:MS) rose 2.6% to $26.65 after swinging to a profit in the fourth quarter.

UnitedHealth (NYSE:UNH) advanced 3.5% to $112.93 after posting fourth-quarter earnings per share of $1.40 and revenue of $43.6bn.

Johnson & Johnson (NYSE:JNJ) rose 0.9% to $97.88 after saying it will cut up to 6% of its workforce in its medical-devices division.

FALLERS

Amarantus BioScience Holdings (OTCMKTS:AMBS) fell 25% to $0.276, reversing an earlier gain. The biotechnology company entered into a letter of intent with Avant Diagnostics (OTCBB:AVDX), a medical diagnostic technology company, to merge an Amarantus wholly-owned unit, Amarantus Diagnostics, into Avant Diagnostics. Shares of Avant rose 195 to $0.25.

Payment Data Systems (NASDAQ:PYDS) slid 1% to $2.08, erasing an earlier gain. The integrated payment solutions provider announced record transaction processing results for the fourth quarter and year ended December 31, 2015.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK